We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bio-Nano-Micro-Informatic Technologies Developed to Help Diagnose DVT and PE

By Labmedica staff writers
Posted on 07 Jan 2008
A European consortium is developing new bio-nano-micro-informatic technologies that will ultimately help clinicians rapidly diagnose patients suspected of deep vein thrombosis (DVT) and pulmonary embolism (PE) at the point-of-first-contact.

Ten European research and high-tech firms are developing a reliable, accurate, mobile, handheld, medical diagnostic prototype device that can be used to rapidly diagnose patients suspected of DVT and PE. More...
Using the latest developments in polymer electronics, biomolecular engineering, lab-on-a-chip, wireless information communications technology (ICT), and nano-bio-technologies, the prototype device will detect D-dimer levels in whole blood. These levels will indicate to healthcare professionals whether they should rule out DVT or refer the patient for further diagnosis. A prototype device will be ready in August of 2009.

The device is expected to improve the speed, accuracy, and reliability with which DVT and related blood clot conditions can be diagnosed at the point-of-first-contact and will enable practitioners to reduce the number of false-positive diagnoses. It will be used at primary point-of-care (POC) locations including hospitals, local clinics, accident and emergency units, doctors' offices, outpatient departments, and by paramedics.

The University of Teesside (Tees Valley, UK) is leading the consortium, which also includes Cenamps (New Castle upon Tyne, UK), Helena Biosciences (Gateshead, UK), Wyeth (Madison, NJ, USA), Fraunhofer Institute (München, Germany), and other companies and universities in Spain, France, Slovakia, and Hungary.


Related Links:
Cenamps
Helena Biosciences
Fraunhofer Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Electrolyte Analyzer
BKE-B
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.